日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial

帕博利珠单抗联合化疗治疗晚期或复发性子宫内膜癌:NRG GY018 3期随机试验的总生存期和探索性分析

Eskander, Ramez N; Sill, Michael W; Beffa, Lindsey; Moore, Richard G; Hope, Joanie M; Musa, Fernanda B; Mannel, Robert S; Shahin, Mark S; Cantuaria, Guilherme H; Girda, Eugenia; Lokich, Elizabeth; Kavecansky, Juraj; Leath, Charles A 3rd; Gien, Lilian T; Hinchcliff, Emily M; Lele, Shashikant B; Landrum, Lisa M; Backes, Floor; O'Cearbhaill, Roisin E; Baghdadi, Tareq Al; Hill, Emily K; Thaker, Premal H; John, Veena S; Welch, Stephen; Fader, Amanda N; Powell, Matthew A; Aghajanian, Carol

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study

鲁索替尼联合一线新辅助治疗晚期卵巢癌的I期和随机II期研究:NRG肿瘤协作组研究

Landen, Charles N; Buckanovich, Ronald J; Sill, Michael W; Mannel, Robert S; Walker, Joan L; DiSilvestro, Paul A; Mathews, Cara A; Mutch, David G; Hernandez, Marcia L; Martin, Lainie P; Bishop, Erin; Gill, Sarah E; Gordinier, Mary E; Burger, Robert A; Aghajanian, Carol; Liu, Joyce F; Moore, Kathleen N; Bookman, Michael A

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

帕博利珠单抗联合化疗治疗晚期子宫内膜癌

Eskander, Ramez N; Sill, Michael W; Beffa, Lindsey; Moore, Richard G; Hope, Joanie M; Musa, Fernanda B; Mannel, Robert; Shahin, Mark S; Cantuaria, Guilherme H; Girda, Eugenia; Mathews, Cara; Kavecansky, Juraj; Leath, Charles A 3rd; Gien, Lilian T; Hinchcliff, Emily M; Lele, Shashikant B; Landrum, Lisa M; Backes, Floor; O'Cearbhaill, Roisin E; Al Baghdadi, Tareq; Hill, Emily K; Thaker, Premal H; John, Veena S; Welch, Stephen; Fader, Amanda N; Powell, Matthew A; Aghajanian, Carol

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study

拓扑替康联合紫杉醇一线治疗晚期宫颈癌的最终生存分析:一项NRG肿瘤学随机研究

Tewari, Krishnansu S; Sill, Michael W; Birrer, Michael J; Penson, Richard T; Huang, Helen; Moore, David H; Ramondetta, Lois M; Landrum, Lisa M; Oaknin, Ana; Reid, Thomas J; Leitao, Mario M; Michael, Helen E; Monk, Bradley J

Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study

一项随机 II 期试验比较了纳武利尤单抗与纳武利尤单抗联合伊匹木单抗治疗复发性或持续性卵巢癌的疗效:NRG 肿瘤学研究

Zamarin, Dmitriy; Burger, Robert A; Sill, Michael W; Powell, Daniel J Jr; Lankes, Heather A; Feldman, Michael D; Zivanovic, Oliver; Gunderson, Camille; Ko, Emily; Mathews, Cara; Sharma, Sudarshan; Hagemann, Andrea R; Khleif, Samir; Aghajanian, Carol

Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062)

晚期宫颈癌中的循环肿瘤细胞:NRG肿瘤-妇科肿瘤组研究240(NCT 00803062)

Tewari, Krishnansu S; Sill, Michael W; Monk, Bradley J; Penson, Richard T; Moore, David H; Lankes, Heather A; Ramondetta, Lois M; Landrum, Lisa M; Randall, Leslie M; Oaknin, Ana; Leitao, Mario M; Eisenhauer, Eric L; DiSilvestro, Paul; Van Le, Linda; Pearl, Michael L; Burke, James J; Salani, Ritu; Richardson, Debra L; Michael, Helen E; Kindelberger, David W; Birrer, Michael J

Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study

在贝伐珠单抗联合化疗治疗晚期宫颈癌的随机试验中,停止抗血管生成治疗时患者报告的结局:一项NRG肿瘤学组研究

Chase, Dana; Huang, Helen Q; Monk, Bradley J; Ramondetta, Lois Michelle; Penson, Richard T; Gil, Karen; Landrum, Lisa M; Leitao, Mario; Oaknin, Ana; Huh, Warner K; Pulaski, Heather L; Robison, Katina; Guntupalli, Saketh R; Richardson, Debra; Salani, Ritu; Sill, Michael W; Wenzel, Lari B; Tewari, Krishnansu Sujata

Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study

贝伐珠单抗联合福斯布瑞他林治疗复发性卵巢癌:一项随机II期NRG肿瘤/妇科肿瘤组研究的总生存期和探索性分析

Tewari, Krishnansu S; Sill, Michael W; Coleman, Robert L; Aghajanian, Carol; Mannel, Robert; DiSilvestro, Paul A; Powell, Matthew; Randall, Leslie M; Farley, John; Rubin, Stephen C; Monk, Bradley J

A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study

一项卡博替尼与每周一次紫杉醇治疗持续性或复发性上皮性卵巢癌、输卵管癌或原发性腹膜癌的随机II期研究:NRG肿瘤学/妇科肿瘤学组研究

Matulonis, Ursula A; Sill, Michael W; Makker, Vicky; Mutch, David G; Carlson, Jay W; Darus, Christopher J; Mannel, Robert S; Bender, David P; Crane, Erin K; Aghajanian, Carol

Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial

紫杉醇联合或不联合帕唑帕尼治疗持续性或复发性卵巢癌:一项随机临床试验

Richardson, Debra L; Sill, Michael W; Coleman, Robert L; Sood, Anil K; Pearl, Michael L; Kehoe, Siobhan M; Carney, Michael E; Hanjani, Parviz; Van Le, Linda; Zhou, Xun C; Alvarez Secord, Angeles; Gray, Heidi J; Landrum, Lisa M; Lankes, Heather A; Hu, Wei; Aghajanian, Carol